Open Nav

Harri Sihto

Chairman of the Board

Sartar Therapeutics

Harri Sihto, Ph.D., is a biochemist and an Adjunct Professor in Cancer Biology at the University of Helsinki. Dr. Sihto is a co-founder and Chairman of the Board of Sartar Therapeutics and takes care of the management of the company at the moment. He have over 15 years’ experience of molecular cancer research. His current research has focused on prognostic factors and novel therapeutic targets in rare cancers.

This speaker's sessions: